VIR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

VIRVir Biotechnology, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

VIRVir Biotechnology, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VIR 8

ALNYAlnylamsupplier

XNCRXencorsupplier

SNYSanofisupplier

—Astellasunlistedcustomer

4 more · VIR chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

VIRVir Biotechnology, Inc.

12.20▲+10.71%· post 12.30

Mkt cap$1.9BRevenue$239MQ2 FY26Revenue$74MFY24

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

VIRVir Biotechnology, Inc.

AMGNAmgen Inc

12.20▲+10.71%post 12.30

Price

460.55▲+0.06%post 460.42

$1.9B

Mkt cap

$249.0B

Q2 FY26$239M

Revenue

$10.4BQ3 FY26

FY24$74M

Revenue

$36.8BFY25

VIR12.20▲+10.71%vsAMGN460.55▲+0.06%ClosedNov 6 '26